Comment on bibliometric and visual analysis of vaccination hesitancy research

Comment on bibliometric and visual analysis of vaccination hesitancy research

Bibliographic Details
Main Authors:	Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-08-01
Series:	Human Vaccines & Immunotherapeutics
Online Access:	http://dx.doi.org/10.1080/21645515.2023.2238575

Similar Items

Addressing COVID-19 vaccine hesitancy
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-11-01)

Comments on “Identifying psychological antecedents and predictors of vaccine hesitancy through machine learning: A cross sectional study among chronic disease patients of deprived urban neighbourhood, India”
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-09-01)

Vaccine hesitancy in the refugee, immigrant, and migrant population: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-12-01)

Comment on “Knowledge, Attitude, and Acceptability of COVID-19 Vaccine”
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Comment on “Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story”
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-03-01)

Antineutrophil cytoplasmic antibody, glomerulonephritis and inactivated SARS‐CoV‐2 vaccine: comment on the article by Garcia et al
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-08-01)

Comment to: Post-vaccination incidence and side effects of COVID-19 in a cohort of Brazilian healthcare professionals: an internet-based survey
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-04-01)

Ensuring Interrater Reliability When Evaluating Voice Assistants. Comment on “Evaluating Voice Assistants’ Responses to COVID-19 Vaccination in Portuguese: Quality Assessment”
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-03-01)

Reply letter to “Comment on bibliometric and visual analysis of vaccination hesitancy research”
by: Chaojian Chen, et al.
Published: (2023-08-01)

Pox: smallpox vs monkeypox.: comment
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Comments on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Peripheral Blood Smear in COVID-19: a Comment
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-02-01)

Hypoparathyroidism in a COVID-19 vaccine recipient: An issue for further research
by: Rujittika Mungmunpuntipantip, et al.
Published: (2024-01-01)

Comment on fetal gestational age determination using ultrasound placental thickness
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-01-01)

COVID-19-induced acute kidney injury and chronic kidney disease: comment
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-09-01)

Comment on “Maternal uniparental disomy 21 in association with low-level mosaic trisomy 21 at amniocentesis”
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-07-01)

Concurrent administration of COVID-19 vaccine and seasonal influenza vaccine: Expected rate of adverse effect
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Effect of COVID-19 vaccination on epileptic seizures in patients with epilepsy: Correspondence human vaccines & immunotherapeutics
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-12-01)

COVID-19 Vaccination in Cancer Patients: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-11-01)

COVID-19 vaccine and its effect on sperm
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Myocarditis and COVID-19 mRNA vaccination
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-08-01)

COVID-19 Vaccination and Abnormal Blood Glucose Level
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Parsonage–Turner syndrome and COVID-19 vaccine: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Abnormal thyroid function following COVID-19 vaccination
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-01-01)

Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Expected response to the additional fifth dose of COVID-19 vaccine
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Attitude and perception of COVID-19 vaccines and healthcare workers: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Correspondence on Intention to vaccinate young children against COVID-19
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-11-01)

Subacute thyroiditis and different SARS-CoV-2 vaccine
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-11-01)

New COVID-19 vaccine, thiomerosol, and reversible cerebral vasoconstriction
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-01-01)

Acute kidney injury after COVID-19 vaccines: correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-12-01)

Response to case report on myocarditis and pericarditis after COVID‐19 vaccination
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-10-01)

Multiple sclerosis patients’ response to COVID-19 pandemic and vaccination: correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Safety and adverse events following COVID‐19 vaccination and epilepsy: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-03-01)

Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies
by: rujittika mungmunpuntipantip, et al.
Published: (2022-06-01)

Post-vaccination antibodies against SARS-CoV-2: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-12-01)

SARS-CoV-2 reinfection rate in vaccinated Hospital workers: correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-01-01)

Willingness to pay for a COVID-19 vaccine for oneself and one's child: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023-01-01)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-11-01)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-10-01)